Business Description
Genix Pharmaceuticals Corp
NAICS : 325412
SIC : 3741
ISIN : CA0209261019
Description
Genix Pharmaceuticals Corp is a Canadian life sciences company. It operates as a formulator, manufacturer, licensor, and marketer of life sciences-related products with a focus on nutraceuticals and pharmaceuticals.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.02 | |||||
| Equity-to-Asset | -4.84 | |||||
| Debt-to-Equity | -0.48 | |||||
| Debt-to-EBITDA | -0.15 | |||||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | -129.12 | |||||
| Beneish M-Score | -15.56 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | -109.1 | |||||
| 3-Year EPS without NRI Growth Rate | 15.7 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 51.39 | |||||
| 9-Day RSI | 48.88 | |||||
| 14-Day RSI | 52.21 | |||||
| 6-1 Month Momentum % | 50 | |||||
| 12-1 Month Momentum % | 50 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.17 | |||||
| Quick Ratio | 0.05 | |||||
| Cash Ratio | 0.01 | |||||
| Days Inventory | 6618.67 | |||||
| Days Sales Outstanding | 272.09 | |||||
| Days Payable | 10901.33 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Shareholder Yield % | -8.5 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 18.18 | |||||
| Operating Margin % | -6372.73 | |||||
| Net Margin % | -38427.27 | |||||
| FCF Margin % | -1936.36 | |||||
| ROE % | -355.15 | |||||
| ROA % | -169.16 | |||||
| ROIC % | -21.47 | |||||
| ROC (Joel Greenblatt) % | -166400 | |||||
| ROCE % | -349.64 | |||||
| Years of Profitability over Past 10-Year | 2 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| EV-to-EBIT | -0.99 | |||||
| EV-to-EBITDA | -1.1 | |||||
| EV-to-Revenue | 374.55 | |||||
| EV-to-FCF | -17.95 | |||||
| Earnings Yield (Greenblatt) % | -100.86 | |||||
| FCF Yield % | -6 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Genix Pharmaceuticals Corp Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil C$) | 0.011 | ||
| EPS (TTM) (C$) | -0.068 | ||
| Beta | 0.36 | ||
| Volatility % | 161.82 | ||
| 14-Day RSI | 52.21 | ||
| 14-Day ATR (C$) | 0.001794 | ||
| 20-Day SMA (C$) | 0.062 | ||
| 12-1 Month Momentum % | 50 | ||
| 52-Week Range (C$) | 0.015 - 0.075 | ||
| Shares Outstanding (Mil) | 59.22 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Genix Pharmaceuticals Corp Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Genix Pharmaceuticals Corp Stock Events
| Event | Date | Price(C$) | ||
|---|---|---|---|---|
| No Event Data | ||||
Genix Pharmaceuticals Corp Frequently Asked Questions
What is Genix Pharmaceuticals Corp(TSXV:GENX)'s stock price today?
The current price of TSXV:GENX is C$0.06. The 52 week high of TSXV:GENX is C$0.08 and 52 week low is C$0.02.
When is next earnings date of Genix Pharmaceuticals Corp(TSXV:GENX)?
The next earnings date of Genix Pharmaceuticals Corp(TSXV:GENX) is .
Does Genix Pharmaceuticals Corp(TSXV:GENX) pay dividends? If so, how much?
Genix Pharmaceuticals Corp(TSXV:GENX) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers